Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Immunovant, Inc. (IMVT)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -73.9-63.2-40.4-47.2-41.4-37.7-30.5-28.2
Depreciation and amortization   [+]0.1 0.00.00.00.10.00.0
Stock-based compensation  10.7 7.711.910.212.23.95.5
Change in working capital   [+]15.8 -33.225.80.013.74.916.2
Other operating activities  0.0 0.0-23.5-0.7-29.60.5-16.1
Cash from operations  -47.4-63.2-65.8-33.0-31.9-41.3-21.2-22.5
   
Capital expenditures  0.00.00.0-0.1-0.1-0.10.0-0.1
Cash from investing  0.00.00.0-0.1-0.1-0.10.0-0.1
   
Repurchase of common stock, net     -200.0-200.0200.0  
Option exercises  0.9 0.0     
Other cash from financing  1.8 0.0200.0200.00.10.10.8
Cash from financing  0.90.00.00.00.0200.10.10.8
   
Free cash flow  -47.4-63.2-65.9-33.1-32.0-41.3-21.2-22.6
        Per share (diluted)  ($0.36)($0.49)($0.57)($0.30)($0.28)($0.38)($0.22)($0.26)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy